Author: Kherlen Martin

OSP, in collaboration with CISCRP, will be hosting a listening session on strategies for engaging the public as partners in clinical research.  This listening session is in follow-up to NIH’s announcement of the launch of the first phase of public outreach for the new ENGAGE Initiative.

The listening session will be held on July 17, 2024, from 1:00 p.m. – 2:30 p.m. ET. OSP and CISCRP welcome all members of the public to share their thoughts and experiences on engagement in clinical research during this virtual listening session.  Registration for this event is required. Full details, including agenda, webcast information, how to register, and how to sign up to provide comments can be found on the event webpage.

Further information about the purpose and goals of ENGAGE can also be found at: https://partnersinresearch.nih.gov/

Questions may be sent to [email protected]. 

If you are not yet a subscriber to this listserv, please sign up here.  Also, please consider following us on X @NIH_OSP  and LinkedIn. 

NIH is releasing a draft of its updated Public Access Policy in support of its mission to advance access to NIH-funded research results.  The draft policy outlines how NIH proposes to address the Administration’s 2022 Memo on Ensuring Free, Immediate, and Equitable Access to Federally Funded Research through additional steps to accelerate access.

Additionally, NIH is proposing supplementary draft guidance on government use license and rights and publication costs to assist the community with implementing the proposal.  These materials reflect input received in response to the February 2023 NIH Plan to Enhance Public Access to the Results of NIH-Supported Research.

Public comments on the NIH’s Draft Public Access Policy and draft Supplemental Guidance will be accepted until August 19, 2024, and can be submitted through the comment portal found here.

Questions may be sent to [email protected]. 

If you are not yet a subscriber to this listserv, please sign up here.  Also, please consider following us on X @NIH_OSP  and LinkedIn. 

NIH considers patients, communities, and other members of the public to be essential partners in research and is seeking public input on preferences, experiences, and recommendations relating to increasing public engagement in all phases of clinical research.

To accomplish this goal, NIH asked the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) to form the ENGAGE Working Group, which includes patients, advocates, researchers, clinicians, non-profit representatives, and more. Today, NIH is launching the first phase of public outreach via a host of events and resources.

Upcoming Events and Resources 

• The new NIH ENGAGE webpage contains background information about clinical research engagement, the Engage Working Group, upcoming NIH events, and more.

• NIH released a request for information today seeking public feedback to inform the efforts of the ENGAGE Working Group.

• The NExTRAC will be meeting on June 17, 2024 to discuss the Engage Working Group’s progress to date. 

• NIH will be hosting an informational webinar related to the request for information on July 17, 2024, which will also include significant time for public feedback. More details will be provided shortly.  

• Read our blog to learn more about clinical research engagement and the efforts of the Engage Working Group.

Questions may be sent to [email protected]. 

If you are not yet a subscriber to this listserv, please sign up here.  Also, please consider following us on X @NIH_OSP  and LinkedIn. 

On June 17, 2024, from 11:30 am – 1:00 pm ET, NIH will be hosting a virtual meeting of the NExTRAC.  At this meeting, the committee will receive an update from the Working Group on Engaging the Public as Partners in Clinical Research and discuss the next steps regarding its current charge.

A draft agenda, webcast information, details on how to submit written comments, and other meeting materials can be found on the meeting page of the OSP Website.

If you are not yet a subscriber to this listserv, please sign up here. Questions may be sent to [email protected]. Also, please consider following us on X @NIH_OSP  and LinkedIn.